Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS®) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)?

Prescriptions for Benzodiazepines (BZDs) have risen continually. According to national statistics, the combination of BZDs with opioids has increased since 1999. BZDs (sometimes called “benzos”) work to calm or sedate a person by raising the level of the inhibitory neurotransmitter GABA in the brain...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Syst Integr Neurosci
Glavni autori: Blum, K, Gold, M, Modestino, EJ, Baron, D, Boyett, B, Siwicki, D, Lott, L, Podesta, A, Roy, AK, Hauser, M, Downs, BW, Badgaiyan, RD
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6865059/
https://ncbi.nlm.nih.gov/pubmed/31750006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15761/JSIN.1000196
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items